Pelthos Therapeutics terminates executive Francis Knuettel II without cause

Pelthos Therapeutics Inc. terminated the employment of Francis Knuettel II effective April 10, 2026, providing $430,000 in separation pay plus 12 months of base salary. The executive departure represents a leadership change at the biopharmaceutical company.